- Home
- JBGS vs TLRY Comparison
JBGS vs TLRY Comparison
Compare JBGS & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBGS | TLRY |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.3M | 688.9M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | JBGS | TLRY |
|---|---|---|
| Price | $14.25 | $5.29 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $15.00 | ★ $72.33 |
| AVG Volume (30 Days) | 566.2K | ★ 7.0M |
| Earning Date | 05-05-2026 | 04-01-2026 |
| Dividend Yield | ★ 4.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $498,598,000.00 | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.03 | $0.36 |
| 52 Week High | $24.30 | $15.70 |
Technical Indicators
Market Signals| Indicator | JBGS | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 40.16 | 32.23 |
| Support Level | $14.17 | $1.12 |
| Resistance Level | $16.07 | $7.01 |
| Average True Range (ATR) | 0.48 | 0.25 |
| MACD | -0.10 | -0.07 |
| Stochastic Oscillator | 1.87 | 4.99 |
Price Performance
Historical ComparisonAbout JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.